Lisata Therapeutics, Inc. (LSTA) Balance Sheet
LSTA balance sheet, 2025
December 31, 2025 · U.S. dollars$17.7M assets = $3.1M liabilities + $14.6M equity
Both columns are drawn to the same scale: what LSTA owns equals what it owes plus shareholders’ equity. Hover a block for its value.
LSTA financial health
Descriptive bands, not a rating. Fiscal 2025.
LSTA balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $51.8M2016 | $17.7M2025 | −11.2%/yr | |
| Total liabilities | $47.8M2016 | $3.1M2025 | −26.1%/yr | |
| Shareholders’ equity | $4.9M2016 | $14.9M2025 | +13.2%/yr | |
| Cash & short-term investments | $14.7M2016 | $16.0M2025 | +0.9%/yr | |
| Total debt | $6.8M2016 | $137,0002024 | −38.6%/yr | |
| Net cash (debt) | $7.9M2016 | $31.1M2024 | +$23.2M | |
| Working capital | $5.1M2016 | $14.6M2025 | +$9.5M | |
| Book value per share | $25.012021 | $1.712025 | −48.9%/yr | |
| Current ratio | 1.262016 | 5.762025 | +4.50 | |
| Debt / equity | 1.392016 | 0.002024 | −1.39 | |
| Shares outstanding | 3.7M2021 | 8.7M2025 | +23.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
LSTA assets
LSTA liabilities and equity
LSTA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
LSTA balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $16.0M | $31.2M | $50.5M | $69.2M | $95.0M | $34.6M | $25.2M | $43.1M | $55.1M | $14.7M |
| Cash & equivalents | $16.0M | $16.2M | $22.6M | $32.2M | $24.6M | $16.5M | $14.0M | $10.3M | $29.2M | $14.7M |
| Short-term investments | $0 | $15.0M | $27.9M | $37.1M | $70.3M | $18.1M | $11.1M | $32.8M | $25.9M | — |
| Receivables | $700,000 | $900,000 | $1.0M | $0 | $0 | $0 | $0 | $0 | $234,461 | $138,774 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5.0M | $3.6M |
| Other current assets | $1.0M | $2.4M | $2.4M | $2.6M | $1.2M | $758,000 | $815,000 | $1.1M | $790,514 | $6.2M |
| Total current assets | $17.7M | $34.6M | $53.9M | $71.9M | $96.2M | $35.3M | $26.0M | $44.1M | $61.1M | $24.6M |
| Property, plant & equipment (net) | $18,000 | $72,000 | $175,000 | $296,000 | $62,000 | $57,000 | $100,000 | $165,000 | $256,900 | $17.1M |
| Goodwill & intangible assets | $0 | $192,000 | $263,000 | $334,000 | $0 | $0 | $0 | $0 | $0 | $9.3M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $23,000 | $160,000 | $332,000 | $528,000 | $764,000 | $614,000 | $1.1M | $309,000 | $2.0M | $713,572 |
| Total assets | $17.7M | $35.0M | $54.7M | $73.0M | $97.0M | $36.0M | $27.2M | $44.6M | $63.4M | $51.8M |
| Liabilities | ||||||||||
| Accounts payable | $1.0M | $1.3M | $2.4M | $2.7M | $1.9M | $1.0M | $1.5M | $762,000 | $1.3M | $2.2M |
| Short-term debt | — | $137,000 | $168,000 | $180,000 | $229,000 | $370,000 | $354,000 | — | $159,000 | $3.7M |
| Deferred revenue | — | — | — | — | — | — | $2.5M | — | — | $5.1M |
| Total current liabilities | $3.1M | $5.6M | $6.6M | $6.4M | $4.5M | $3.5M | $6.0M | $5.6M | $9.3M | $19.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $0 | $137,000 | $168,000 | $485,000 | $714,000 | $624,000 | $354,000 | — | — | — |
| Other long-term liabilities | $72,000 | $72,000 | $210,000 | $327,000 | $485,000 | $254,000 | $624,000 | $1.5M | $3.9M | $28.3M |
| Total liabilities | $3.1M | $5.7M | $6.8M | $6.7M | $5.0M | $3.8M | $6.6M | $7.1M | $13.2M | $47.8M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $9,000 | $8,000 | $8,000 | $8,000 | $4,000 | $19,000 | $11,000 | $10,000 | $9,484 | $8,206 |
| Retained earnings (deficit) | −$564.7M | −$548.1M | −$528.1M | −$507.2M | −$453.0M | −$425.6M | −$417.4M | −$398.0M | −$381.8M | −$404.8M |
| Accumulated other comprehensive income | −$37,000 | −$81,000 | −$42,000 | −$29,000 | −$70,000 | −$13,000 | $2,000 | −$32,000 | −$27,978 | $0 |
| Minority interest | −$254,000 | −$254,000 | −$254,000 | −$254,000 | — | — | — | — | — | — |
| Total shareholders' equity | $14.9M | $29.6M | $48.1M | $66.6M | $92.3M | $32.5M | $20.8M | $37.7M | $50.5M | $4.9M |
| Key figures | ||||||||||
| Total debt | — | $137,000 | $168,000 | $485,000 | $714,000 | $624,000 | $978,000 | — | $159,180 | $6.8M |
| Net cash (debt) | — | $31.1M | $50.4M | $68.7M | $94.3M | $33.9M | $24.2M | — | $54.9M | $7.9M |
| Working capital | $14.6M | $29.0M | $47.3M | $65.5M | $91.7M | $31.8M | $20.0M | $38.5M | $51.8M | $5.1M |
| Tangible book value | $14.9M | $29.4M | $47.9M | $66.2M | $92.3M | $32.5M | $20.8M | $37.7M | $50.5M | −$4.4M |
| Book value per share | $1.71 | $3.55 | $5.96 | $12.85 | $25.01 | — | — | — | — | — |
| Shares outstanding | 8.7M | 8.3M | 8.1M | 5.2M | 3.7M | — | — | — | — | — |
| Current ratio | 5.76 | 6.16 | 8.18 | 11.26 | 21.27 | 10.08 | 4.35 | 7.85 | 6.56 | 1.26 |
| Quick ratio | 5.42 | 5.73 | 7.82 | 10.85 | 21.00 | 9.86 | 4.21 | 7.66 | 5.94 | 0.76 |
| Debt / equity | — | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.05 | — | 0.00 | 1.39 |
| Equity / assets | 83.7% | 84.5% | 88.0% | 91.2% | 95.1% | 90.3% | 76.7% | 84.6% | 79.7% | 9.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $10.4M | $13.1M | $16.0M | $19.0M | $22.0M | $25.8M | $31.2M | $35.9M | $38.3M | $43.3M | $50.5M | $54.4M |
| Cash & equivalents | $10.4M | $13.1M | $16.0M | $19.0M | $16.8M | $20.2M | $16.2M | $19.5M | $28.3M | $21.8M | $22.6M | $32.4M |
| Short-term investments | — | — | $0 | $0 | $5.1M | $5.6M | $15.0M | $16.3M | $10.0M | $21.5M | $27.9M | $22.0M |
| Receivables | $200,000 | $0 | $700,000 | $1.2M | $501,000 | $750,000 | $900,000 | $200,000 | $1.0M | $1.0M | $1.0M | $500 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$500 |
| Other current assets | $370,000 | $960,000 | $1.0M | $1.4M | $2.4M | $2.0M | $2.4M | $1.6M | $2.7M | $3.2M | $2.4M | $2.8M |
| Total current assets | $11.0M | $14.0M | $17.7M | $21.6M | $24.9M | $28.6M | $34.6M | $37.7M | $42.0M | $47.6M | $53.9M | $57.2M |
| Property, plant & equipment (net) | $14,000 | $16,000 | $18,000 | $22,000 | $48,000 | $74,000 | $72,000 | $96,000 | $119,000 | $146,000 | $175,000 | $204,000 |
| Goodwill & intangible assets | $0 | $0 | $0 | $139,000 | $157,000 | $174,000 | $192,000 | $210,000 | $228,000 | $245,000 | $263,000 | $281,000 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $23,000 | $23,000 | $23,000 | $70,000 | $116,000 | $160,000 | $201,000 | $246,000 | $290,000 | $332,000 | $371,000 |
| Total assets | $11.0M | $14.1M | $17.7M | $21.8M | $25.2M | $29.0M | $35.0M | $38.2M | $42.6M | $48.2M | $54.7M | $58.1M |
| Liabilities | ||||||||||||
| Accounts payable | $836,000 | $510,000 | $1.0M | $619,000 | $782,000 | $602,000 | $1.3M | $556,000 | $728,000 | $1.3M | $2.4M | $1.3M |
| Short-term debt | — | — | — | — | $47,000 | $92,000 | $137,000 | $181,000 | $176,000 | $172,000 | $168,000 | $164,000 |
| Deferred revenue | — | — | — | — | — | — | — | — | −$728,000 | — | — | −$164,000 |
| Total current liabilities | $3.0M | $3.3M | $3.1M | $4.6M | $4.3M | $3.8M | $5.6M | $4.7M | $4.5M | $5.3M | $6.6M | $5.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | $0 | $0 | $47,000 | $92,000 | $137,000 | $181,000 | $176,000 | $172,000 | $168,000 | $164,000 |
| Other long-term liabilities | $50,000 | $72,000 | $72,000 | $72,000 | $72,000 | $72,000 | $72,000 | $72,000 | $119,000 | $164,000 | $210,000 | $253,000 |
| Total liabilities | $3.0M | $3.4M | $3.1M | $4.6M | $4.4M | $3.9M | $5.7M | $4.8M | $4.6M | $5.5M | $6.8M | $5.4M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $9,000 | $9,000 | $9,000 | $9,000 | $9,000 | $9,000 | $8,000 | $8,000 | $8,000 | $8,000 | $8,000 | $8,000 |
| Retained earnings (deficit) | −$572.1M | −$569.1M | −$564.7M | −$561.7M | −$557.4M | −$552.8M | −$548.1M | −$543.5M | −$538.5M | −$533.5M | −$528.1M | −$522.7M |
| Accumulated other comprehensive income | −$17,000 | −$21,000 | −$37,000 | −$42,000 | −$50,000 | −$78,000 | −$81,000 | −$32,000 | −$77,000 | −$104,000 | −$42,000 | −$100,000 |
| Minority interest | −$254,000 | −$254,000 | −$254,000 | −$254,000 | −$254,000 | — | — | — | — | — | — | — |
| Total shareholders' equity | $8.2M | $10.9M | $14.9M | $17.4M | $21.0M | $25.4M | $29.6M | $33.7M | $38.2M | $43.0M | $48.1M | $53.0M |
| Key figures | ||||||||||||
| Total debt | — | — | — | — | $47,000 | $92,000 | $137,000 | $181,000 | $176,000 | $172,000 | $168,000 | $164,000 |
| Net cash (debt) | — | — | — | — | $21.9M | $25.7M | $31.1M | $35.7M | $38.1M | $43.2M | $50.4M | $54.2M |
| Working capital | $8.0M | $10.7M | $14.6M | $17.0M | $20.6M | $24.8M | $29.0M | $33.0M | $37.5M | $42.2M | $47.3M | $52.1M |
| Tangible book value | $8.2M | $10.9M | $14.9M | $17.2M | $20.9M | $25.2M | $29.4M | $33.5M | $38.0M | $42.8M | $47.9M | $52.7M |
| Book value per share | $0.91 | $1.21 | $1.71 | $1.99 | $2.44 | $2.95 | $3.55 | $4.05 | $4.60 | $5.18 | $5.91 | $6.51 |
| Shares outstanding | 9.1M | 9.0M | 8.7M | 8.7M | 8.6M | 8.6M | 8.3M | 8.3M | 8.3M | 8.3M | 8.1M | 8.1M |
| Current ratio | 3.69 | 4.23 | 5.76 | 4.72 | 5.77 | 7.52 | 6.16 | 8.03 | 9.42 | 8.92 | 8.18 | 11.15 |
| Quick ratio | 3.56 | 3.94 | 5.42 | 4.42 | 5.21 | 6.98 | 5.73 | 7.69 | 8.81 | 8.32 | 7.82 | 10.60 |
| Debt / equity | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity / assets | 74.8% | 77.7% | 83.7% | 79.8% | 83.6% | 87.5% | 84.5% | 88.2% | 89.8% | 89.1% | 88.0% | 91.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 12, 2026); data from EODHD.
LSTA financial position
At the end of fiscal 2025 (December 31, 2025), Lisata Therapeutics had total assets of $17.7 million (down 49.3% from a year earlier), total liabilities of $3.1 million and shareholders' equity of $14.9 million. Its current ratio was 5.76. In the latest quarter (ended June 30, 2026) total assets were $11.0 million and equity $8.2 million.
Related: LSTA income statement, LSTA cash flow statement, LSTA key metrics. See the LSTA stock overview for the latest quote and news.
LSTA balance sheet FAQ
What are Lisata Therapeutics's total assets?
Lisata Therapeutics reported total assets of $17.7 million at the end of fiscal 2025 (December 31, 2025), compared with $35.0 million a year earlier.
How much cash does Lisata Therapeutics have?
Lisata Therapeutics held $16.0 million in cash and short-term investments at the end of fiscal 2025.
What is Lisata Therapeutics's book value?
Lisata Therapeutics's shareholders' equity (book value) was $14.9 million at the end of fiscal 2025, or $1.71 per share.
What is Lisata Therapeutics's current ratio?
Lisata Therapeutics had current assets of $17.7 million and current liabilities of $3.1 million, a current ratio of 5.76 (it can cover its short-term obligations).